Artificial intelligence (AI)-based risk classification improves prognostication with localized prostate cancer, according to a study published online Oct. 24 in JCO Precision Oncology. Jonathan David ...
The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due ...
The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due ...
Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
LOS ANGELES — A new study has found that the use of a urine test could significantly improve screening for prostate cancer. Prostate cancer screening is currently based on a blood test to detect PSA — ...
Scientists at the University of Cambridge, in collaboration with researchers at the Institute of Cancer Research, London, have developed a new computational algorithm to help predict a man's ...
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more than 253,000 individual cells and identifying previously hidden ...
Aggressive prostate cancers often lose expression of traditional markers after treatment, making it hard to diagnose the tumor’s origin and complicating treatment decisions Researchers sought new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results